Research News for October 2, 2019
advertisement
- Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention (HTML)
- Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic β-Cells (HTML)
- Environmental Factors Associated With Type 1 Diabetes (HTML)
- C-peptide persistence in type 1 diabetes: ‘not drowning, but waving’? (HTML)
- In Vivo Assessment of T cell Kinetics in Individuals at Risk for Type 1 Diabetes (HTML)
- Onset of type 1 diabetes mellitus in rural areas of the USA (HTML)
- The Transatlantic HbA1c gap: differences in glycaemic control across the life-span between the US T1D Exchange and German/Austrian DPV registries (HTML)
- Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years (HTML)
- Influence of duration of type 1 diabetes on long-term pancreatic transplant outcomes (HTML)
- Two-Dimensional Speckle Tracking Versus Applanation Tonometry in Evaluation of Subclinical Atherosclerosis in Children with Type 1 Diabetes Mellitus
- New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes (HTML)
- Does control of glycemia regulate immunological parameters in insulin-treated persons with type 1 diabetes? (HTML)
- Integrating the Patient Health Questionnaire-2 depression screening tool into the paediatric diabetes clinic (HTML)
- Type 1 Diabetes Accelerates Progression of Coronary Artery Calcium Over the Menopausal Transition: The CACTI Study (HTML)
- Progression of Diabetic Kidney Disease in the Absence of Albuminuria (HTML)
- Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A Six-Month Phase 2b Study in Type 1 Diabetes (HTML)
